As part of the deal, KKR will purchase up to 54 per cent of HCG's equity from CVC Asia V at a price of INR 445 per share.

As part of the transaction, KKR will acquire up to 54 per cent of equity in HCG from CVC Asia V at a purchase price of Rs 445 per share

Boosted by the development, Healthcare Global shares rose 3.5% to ₹517.85 in early trade today, while the market capitalisation climbed to ₹7,175 crore. The healthcare stock opened higher at ₹502.15 against Friday’s closing price of ₹500 apiece.

US-based investment company KKR has agreed to acquire a stake of up to 54% in Healthcare Global Enterprises (HCG), an oncology hospital chain in India, for $400m. KKR will acquire the stake in HCG from global private markets manager CVC Asia V at a rate of Rs445 ($5.

American private equity fund KKR will acquire a 51% stake in HealthCare Global Enterprises for Rs 3,203 crore, making an open offer for an additional

US private equity firm KKR & Co. will acquire a majority stake in HealthCare Global Enterprises Ltd. for around Rs 3,350 crore.

KKR said it has agreed to acquire a controlling stake in cancer treatment chain HealthCare Global Enterprises Ltd (HCG) from fellow private equity firm CVC for ₹445 per share, amounting to around $400 million.